Joan B. Soriano

Jul 25, 2024 | erj.ersjournals.com | Joan B. Soriano |Sara Lumbreras |Christine Jenkins

Conflict of interest: J.B. Soriano reports grants from Chiesi, GSK, Linde and Novartis via Hospital Universitario de La Princesa, and from 2020 to 2024 participated in speaking activities, advisory committees and consultancies for Air Liquide, Almirall, AstraZeneca, Boehringer Ingelheim, CHEST, Chiesi, CNPT, ERS, FTH, Gebro, Grifols, GSK, IHME, Laminar Pharma, Linde, Lipopharma, Menarini, Mundipharma, Novartis, OMS/WHO, Pfizer, ResApp, RiRL, ROVI, SEPAR, Seqirus, WHO EUR, Takeda and Zambon;...

Jul 18, 2024 | erj.ersjournals.com | Joan B. Soriano

Footnotes Conflict of interest: J.B. Soriano has received grants (from 2020 to 2024) from Chiesi, GSK, Linde and Novartis via Hospital Universitario de La Princesa, and participated in speaking activities, advisory committees and consultancies (from 2020 to 2024) sponsored by Air Liquide, Almirall, AstraZeneca, Boehringer Ingelheim, CHEST, Chiesi, CNPT, ERS, FTH, Gebro, Grifols, GSK, IHME, Laminar Pharma, Linde, Lipopharma, Menarini, Mundipharma, Novartis, OMS/WHO, OPRI, Pfizer, ResApp, RiRL,...

Jun 27, 2024 | bmjopenrespres.bmj.com | Francisco García-Río |Marc Miravitlles |Joan B. Soriano |Borja G. Cosío

MethodsEPISCAN II is a national, multicentre, cross-sectional, population-based epidemiological study, whose protocol, fieldwork and methods have been previously described.15 16 Briefly, the study was conducted at 20 teaching hospitals throughout Spain from April 2017 to February 2019. Patients and public were not involved in the development of the research question, design or recruitment; no patient advisors were required, and data were analysed anonymously.

May 31, 2024 | sciencedirect.com | Joan B. Soriano

With pollution being recognized as an environmental risk factor for increased morbidity and mortality, studying the prevalence of COPD and the proximity of toxic release inventory (TRI) sites is significant for public health interventions to improve respiratory health 1, 2, 3, 4, 5, 6. Beyond COPD prevalence, several other factors contribute to the vulnerability of individuals living with COPD.

May 18, 2024 | resmedjournal.com | Joan B. Soriano |Facultat de Medicina |Palma de Mallorca |Servicio de Neumología

Frank E. Anderson C. Rubinstein D. Frequency of sexual dysfunction in "normal" couples. N Engl J Med. 1978 Jul 20; 299 (): 111-115https://doi.org/10.1056/NEJM197807202990302Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav.